These findings are in accordance with the results of Carro et al [42] showing that the expression of C/EBPβ is linked to the mesenchymal state of primary glioblastoma and provides an excellent prognostic biomarker for tumor aggressiveness. This evidence concerns the gene CEBPB and glioblastoma.